Market Research Industry Today
Hemostats Market Size, Share: Industry Trends and Forecast 2018-2024
“Global Hemostats Market”, By Product Type (Thrombin Based, Combination, Oxidized Regenerated Cellulose Based, Gelatin Based, Collagen Based Hemostats), By Indication (Wound Closure, Surgery), By End-User (Hospitals, Clinics, Ambulatory Centers, Community Healthcare, Others), By Geography (North America, South America, Europe, Asia-Pacific, Middle East and Africa) and Forecast to 2024.
Published 21 June 2018
Global Hemostats Market is expected to reach USD 4.5 billion by 2024 from USD 2.7 billion in 2016, at a CAGR of 6.6% in the forecast period 2017 to 2024. The new market report contains data for historic years 2015, the base year of calculation is 2016 and the forecast period is 2017 to 2024.
Get Free Sample Report @ http://databridgemarketresearch.com/request-a-sample/?dbmr=global-hemostats-market
Key Drivers of Global Hemostats Market:
Some of the major factors driving the market for hemostats market are increasing number of surgeries, technological advancement, increasing healthcare expenditure and infrastructure. These factors are increasing the demand for different heomostatic agents.
• No of pages: 278
• No of Figures: 241
• No of Tables: 237
Inquiry Before Buying @ http://databridgemarketresearch.com/inquire-before-buying/?dbmr=global-hemostats-market
Key Points of Global Hemostats Market:
Ethicon US LLC (U.S.) is dominating the hemostats market followed by Pfizer and C.R. Bard Inc., along with others such as Baxter, Vascular Solutions, Inc., B.Braun Melsungen, 3-D Matrix, Ltd., Resorba Medical GmbH (an Advanced Medical Solutions Group plc Company), Anika Therapeutics, Inc., Arch Therapeutics Inc., Biom’Up SAS, CryoLife, Inc., Gamma Therapeutics, Inc., Hemostasis, LLC, MedTrade Products Limited, Integra LifeSciences Corporation, Medline Industries, Inc., HEMOTEC MEDICAL GMBH, Stryker, CSL Behring, Mallinckrodt, and Equimedical, B.V. among other companies.
The Global Hemostats Market is segmented on the basis of type, application, distribution channel, and end user. The global hemostats market is segmented into 5 major types, namely thrombin based hemostats, combination agents, oxidized regenerated cellulose based haemostats, gelatin based haemostats and collagen based haemostats. In 2017, the thrombin based hemostats segment is expected to dominate the market with a share of ~38.0% and collagen agents is expected to grow with the highest CAGR during the forecast period from 2017 to 2024.
On the basis of application, the market is segmented into surgery and wound closure.
On the basis of end users, the market is classified into hospitals, community healthcare, ambulatory centres and clinics. In 2017, the hospital segment is expected to dominate the market and is expected to continue this trend till 2024.
View Full Report @ http://databridgemarketresearch.com/reports/global-hemostats-market/
Key Topics Covered:
1. INTRODUCTION
2. RESEARCH METHODOLOGY
3. MARKET LANDSCAPE SUMMARY
4. PREMIUM INSIGHTS
5. HEMOSTATS MARKET, BY PRODUCT TYPE
6. HEMOSTATS MARKET, BY INDICATION
7. HEMOSTATS MARKET, BY END-USER
8. HEMOSTATS MARKET, BY GEOGRAPHY
9. HEMOSTATS MARKET: COMPETITIVE LANDSCAPE
10. HEMOSTATS MARKET, COMPANY PROFILES
10.1. ETHICON, INC. (A JOHNSON AND JOHNSON COMPANY)
10.2. PFIZER
10.3. C.R. BARD
10.4. BAXTER
10.5. VASCULAR SOLUTIONS, INC.
10.6. B.BRAUN MELSUNGEN
10.7. 3-D MATRIX, LTD
10.8. RESORBA MEDICAL GMBH (A ADVANCED MEDICAL SOLUTIONS GROUP PLC COMPANY)
10.9. ANIKA THERAPEUTICS, INC.
10.10. ARCH THERAPEUTICS INC.
10.11. BIOM’UP SAS
10.12. CRYOLIFE, INC.
10.13. GAMMA THERAPEUTICS, INC.
10.14. HEMOSTASIS, LLC
10.15. MEDTRADE PRODUCTS LTD.
10.16. INTEGRA LIFESCIENCES CORPORATION
10.17. MEDLINE INDUSTRIES, INC.
10.18. HEMOTEC MEDICAL GMBH
10.19. STRYKER
10.20. HEMOSTASIS, LLC.
10.21. CSL BEHRING
10.22. MALLINCKRODT PLC.
10.23. EQUIMEDICAL, B.V.
About Data Bridge Market Research:
Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.
Data Bridge adepts in creating satisfied clients who reckon upon our services and rely on our hard work with certitude. Get 10% Discount on Report by emailing sopan.gedam@databridgemarketresearch.com . We are content with our glorious 99.9 % client satisfying rate.
Contact:
Sopan Gedam
Data Bridge Market Research
Tel: +1-888-387-2818
Email: sopan.gedam@databridgemarketresearch.com
Get Free Sample Report @ http://databridgemarketresearch.com/request-a-sample/?dbmr=global-hemostats-market
Key Drivers of Global Hemostats Market:
Some of the major factors driving the market for hemostats market are increasing number of surgeries, technological advancement, increasing healthcare expenditure and infrastructure. These factors are increasing the demand for different heomostatic agents.
- Reluctance of surgeons towards new products may hinder the growth of this market.
- The weak reimbursement scenario will hamper the growth of the market for new and innovative therapies or hemostats products, causing companies to withdraw from the market thus increasing the hospital costs putting all burdens onto the patient for treatment.
• No of pages: 278
• No of Figures: 241
• No of Tables: 237
Inquiry Before Buying @ http://databridgemarketresearch.com/inquire-before-buying/?dbmr=global-hemostats-market
Key Points of Global Hemostats Market:
Ethicon US LLC (U.S.) is dominating the hemostats market followed by Pfizer and C.R. Bard Inc., along with others such as Baxter, Vascular Solutions, Inc., B.Braun Melsungen, 3-D Matrix, Ltd., Resorba Medical GmbH (an Advanced Medical Solutions Group plc Company), Anika Therapeutics, Inc., Arch Therapeutics Inc., Biom’Up SAS, CryoLife, Inc., Gamma Therapeutics, Inc., Hemostasis, LLC, MedTrade Products Limited, Integra LifeSciences Corporation, Medline Industries, Inc., HEMOTEC MEDICAL GMBH, Stryker, CSL Behring, Mallinckrodt, and Equimedical, B.V. among other companies.
- Combination agents market is growing with the highest CAGR.
- Thrombin based hemostats is driving the market with the highest market share.
- Surgery is dominating the application segment in the hemostats market.
The Global Hemostats Market is segmented on the basis of type, application, distribution channel, and end user. The global hemostats market is segmented into 5 major types, namely thrombin based hemostats, combination agents, oxidized regenerated cellulose based haemostats, gelatin based haemostats and collagen based haemostats. In 2017, the thrombin based hemostats segment is expected to dominate the market with a share of ~38.0% and collagen agents is expected to grow with the highest CAGR during the forecast period from 2017 to 2024.
On the basis of application, the market is segmented into surgery and wound closure.
On the basis of end users, the market is classified into hospitals, community healthcare, ambulatory centres and clinics. In 2017, the hospital segment is expected to dominate the market and is expected to continue this trend till 2024.
View Full Report @ http://databridgemarketresearch.com/reports/global-hemostats-market/
Key Topics Covered:
1. INTRODUCTION
2. RESEARCH METHODOLOGY
3. MARKET LANDSCAPE SUMMARY
4. PREMIUM INSIGHTS
5. HEMOSTATS MARKET, BY PRODUCT TYPE
6. HEMOSTATS MARKET, BY INDICATION
7. HEMOSTATS MARKET, BY END-USER
8. HEMOSTATS MARKET, BY GEOGRAPHY
9. HEMOSTATS MARKET: COMPETITIVE LANDSCAPE
10. HEMOSTATS MARKET, COMPANY PROFILES
10.1. ETHICON, INC. (A JOHNSON AND JOHNSON COMPANY)
10.2. PFIZER
10.3. C.R. BARD
10.4. BAXTER
10.5. VASCULAR SOLUTIONS, INC.
10.6. B.BRAUN MELSUNGEN
10.7. 3-D MATRIX, LTD
10.8. RESORBA MEDICAL GMBH (A ADVANCED MEDICAL SOLUTIONS GROUP PLC COMPANY)
10.9. ANIKA THERAPEUTICS, INC.
10.10. ARCH THERAPEUTICS INC.
10.11. BIOM’UP SAS
10.12. CRYOLIFE, INC.
10.13. GAMMA THERAPEUTICS, INC.
10.14. HEMOSTASIS, LLC
10.15. MEDTRADE PRODUCTS LTD.
10.16. INTEGRA LIFESCIENCES CORPORATION
10.17. MEDLINE INDUSTRIES, INC.
10.18. HEMOTEC MEDICAL GMBH
10.19. STRYKER
10.20. HEMOSTASIS, LLC.
10.21. CSL BEHRING
10.22. MALLINCKRODT PLC.
10.23. EQUIMEDICAL, B.V.
About Data Bridge Market Research:
Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.
Data Bridge adepts in creating satisfied clients who reckon upon our services and rely on our hard work with certitude. Get 10% Discount on Report by emailing sopan.gedam@databridgemarketresearch.com . We are content with our glorious 99.9 % client satisfying rate.
Contact:
Sopan Gedam
Data Bridge Market Research
Tel: +1-888-387-2818
Email: sopan.gedam@databridgemarketresearch.com
Share on Social Media
Contact Information
Sopan Gedam
Data Bridge Market Research
Office Number 402, Amanora Chambers
Magarpatta Road, Hadapsar
Pune
411028
+1 888 387 2818
http://databridgemarketresearch.com/
Other Industry News
Ready to start publishing
Sign Up today!
